LSBCF (LakeShore Biopharma Co) Common Stock: $0.00 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Common Stock?

LakeShore Biopharma Co LSBCF Common Stock is $0.00 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

LakeShore Biopharma Co's quarterly common stock stayed the same from Mar. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) and stayed the same from Sep. 2024 ($0.00 Mil) to Mar. 2025 ($0.00 Mil).

LakeShore Biopharma Co's annual common stock increased from Mar. 2023 ($0.00 Mil) to Mar. 2024 ($0.00 Mil) but then stayed the same from Mar. 2024 ($0.00 Mil) to Mar. 2025 ($0.00 Mil).

LakeShore Biopharma Co Common Stock Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Common Stock Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Common Stock
0.00 0.00 0.00 0.00 0.00

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Common Stock Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

LakeShore Biopharma Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Common Stock of $0.00 Mil as of Mar. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Common Stock too high?
LakeShore Biopharma Co's current Common Stock is $0.00 Mil.
How does LakeShore Biopharma Co's Common Stock compare to ACUT and PPCB?
LakeShore Biopharma Co's Common Stock of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Common Stock is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.